Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-192 in early stage diffuse systemic sclerosis
NCT00043706Phase 2Completed
- Sponsor
- Sanofi
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of metelimumab in diffuse cutaneous systemic sclerosis (dcSSc), sponsored by Sanofi. Status: completed.
02
Drugs
metelimumab
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT00043706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043706.